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Abstract 
The successful prevention of hydrogen peroxide-induced alveolar permeability alterations and cell injury by transferrin-catalase 
conjugate is described in this study. Permeability alterations and cell injury were induced in cultured alveolar epithelial monolayers by 
hydrogen peroxide. Transepithelial transport of a permeability marker, [ HC]mannitol, and cellular nuclear fluorescence of a membrane 
integrity indicator, propidium iodide, were used to quantitate pithelial permeability and damage respectively. Hydrogen peroxide (0.1-10 
mM) induced a dose-dependent i crease in both alveolar permeability and cellular damage; however, the oxidant effect on monolayer 
permeability did not require prior cell damage. Electron spin resonance measurements u ing the spin trap 5,5-dimethyl-l-pyrroline-N-oxide 
indicated the formation of hydroxyl radicals in hydrogen peroxide-treated cells. Chelation of the cellular pool of iron by deferoxamine 
inhibited radical formation and helped protect he cl ls from oxidative changes. Prior treatment of the cells with catalase (0.1 U-10 
U/ml) had minimal protective ffects on cell injury and permeability alterations. In contrast, transferrin-catalase conjugate, at the same 
concentration range, exhibited much improved protective ffects on the cells in response to oxidant stress. This enhanced protection was 
found to correlate well with an increase in cellular uptake of the enzyme conjugate via the transferrin receptor endocytosis pathway. 
Effective protection by the enzyme conjugate was shown to require both the antioxidant enzyme moiety and the cognate moiety for the 
cell surface receptor. These findings indicate the potential therapeutic merit of transferrin-catalase conjugate for the treatment of 
pathological processes in the lung, whenever oxidative stress is involved. 
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1. Introduction 
Alveolar epithelial injury and altered alveolar-capillary 
membrane permeability are important features of oxidative 
pulmonary injury and inflammation [1]. The mechanisms 
of increased epithelial permeability and injury are incom- 
pletely understood, but accumulating evidence suggests the 
involvement of reactive oxygen species such as hydrogen 
peroxide and oxygen free radicals, although the exact 
nature of these radicals is not fully understood in the 
alveolar epithelium. The lungs are normally protected 
against he destructive nature of these oxygen species by a 
variety of mechanisms, notably the intracellular antioxi- 
Abbreviations: SPDP. N-succinimidyl 3-(2-pyridyldithio) propionate; 
PBS, phosphate-buffered saline; HEPES, N-2-hydroxyethylpiperazine-N'- 
2-ethanesulfonic acid; ESR, electron spin resonance: DCFHDA, 2',7'-di- 
chlorofluorescin diacetate. 
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dant enzyme catalase and superoxide dismutase which 
scavenge hydrogen peroxide and superoxide anion respec- 
tively [1,2]. Because of its large surface area, the lung is 
highly vulnerable to inhaled oxidants, particularly the alve- 
olar epithelial lining surface. Nearly 95% of the alveolar 
surface area is covered by type I epithelial ceils. These 
terminally differentiated cells possess low antioxidant en- 
zyme activities and have little regenerative or replicative 
capability [3-5]. In disease states like pulmonary inflam- 
mation and injury, these endogenous enzymes are over- 
whelmed and unchecked oxygen species destroy normal 
cells or alter their functions. 
Therapeutic administration of antioxidant enzymes to 
the lung to augment the endogenous enzymes would there- 
fore serve to neutralize xcess oxidative species and help 
defend against lung toxicity. However, poor accessibility 
of these enzymes to the intracellular target sites of the lung 
epithelium have limited their effective use [6]. The antioxi- 
dant enzyme catalase, for example, was reported to be 
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excluded from cells due to its large molecular size and 
charge [7]. Similarly, superoxide dismutase transport across 
cell membranes was found to be negligible [7]. Strategies 
for enhanced elivery of antioxidant enzymes have, thus 
far, focused on the use of the liposome entrapment sys- 
tems. These systems have permitted intracellular access of 
the enzymes and helped protect he lung from oxidative 
injury [7,8]. However, when administered in vivo, lipo- 
somes can be easily engulfed and eliminated by pulmonary 
phagocytes [9]. Furthermore, when used at high doses, 
liposomes have been reported to cause cellular damage [8]. 
Alternatively, the enzymes may be conjugated with poly- 
mers such as polyethylene glycol to enhance their thera- 
peutic efficacy. Conjugation of antioxidant enzymes with 
polyethylene glycol was shown to reduce pulmonary oxy- 
gen toxicity [10-12]. However, when used at high doses, 
these conjugates were shown to induce suppression of 
endogenous antioxidant enzymes [ 12]. 
As an alternative strategy to improve therapeutic effi- 
cacy of antioxidant enzymes, the present study investigated 
the feasibility of utilizing receptor-mediated en ocytosis as 
a means to enhance cellular uptake of antioxidant en- 
zymes. To accomplish this goal, we utilized a molecular 
conjugate consisting of transferrin, which in this case 
serves as a cognate moiety for the alveolar transferrin 
receptor [13], and the antioxidant enzyme catalase. When 
recognized by the receptor, the conjugate was internalized 
by the efficient endocytosis pathway, co-transporting the 
enzyme. Because this method accomplishes enzyme deliv- 
ery by capitalizing on a normal physiologic ellular pro- 
cess, it is likely to be non-toxic, allowing the potential to 
deliver the enzyme on a repetitive or continuous basis. 
Results from our study showed that such an enzyme 
conjugate system was highly effective in protecting the 
cells from oxidative damage as well as permeability alter- 
ations. 
2. Experimental 
2.1. Preparation of  transferrin-catalase conjugate 
Catalase (EC 1.11.1.6, Sigma) was conjugated to trans- 
ferrin (iron-free, Sigma) through a disulfide linkage with 
the aid of the bifunctional cross-linking agent N-suc- 
cinimidyl 3-(2-pyridyldithio) propionate (SPDP) (Boeh- 
ringer Mannheim), according to the modified method of 
Carlsson et al. [14]. Transferrin (0.05 /zmol) was dissolved 
in 0.5 ml of phosphate-bufferred saline (PBS) (145 mM 
NaCI, 5 mM KC1, 9.35 mM NazHPO 4, 1.9 mM NaHzPO 4) 
(pH 7.4). An ethanol solution (50 /xl) containing 10 mM 
SPDP was added to the stirred protein solution and the 
reaction proceeded for 30 rain at room temperature. Excess 
of the reagent was removed by centrifugal filtration through 
the Durapore TM membrane filter (CLSK, Millipore Corp.) 
at 5000 × g for 30 rain. The modified protein was then 
collected and reconstituted in 0.5 ml sodium acetate buffer 
(pH 4.5). Modification of catalase was similarly performed 
except hat the protein was reconstituted in PBS. 
The transferrin-2-pyridyl disulfide derivative obtained 
was then converted into a thiol derivative by specific 
reduction of the 2-pyridyl disulfide groups with dithiothre- 
itol (10 /~mol) for 30 rain, after which it was filtered and 
reconstituted in 0.5 ml PBS. The modified transferrin was 
then mixed with the catalase-2-pyridyl disulfide derivative 
and, after an 18-h incubation period at 4°C, the reaction 
mixture was centrifugally filtered through the Durapore TM 
CL100K membrane to remove unreacted proteins. The 
disulfide catalase-transferrin co jugate was then collected, 
iron-saturated with ferric citrate (1 /~mol/mg transferrin) 
[15], and stored at 4°C in Hepes-buffered medium for 
further studies. Analysis of the protein conjugate was 
performed using gel permeation chromatography (Phar- 
macia Superose 12 column) with the aid of protein molec- 
ular weight markers [15]. This study showed that the 
conjugate obtained was a monoconjugate. Analysis of 
catalase activity was performed by measuring the decom- 
position of hydrogen peroxide at A240 [16]. One unit of 
catalase is the amount of enzyme that decomposes 1 /zmol 
hydrogen peroxide per rain. The conjugate prepared under 
these conditions retained approx. 87% of its original cata- 
lase activity. 
2.2. Isolation and culture of alveolar epithelial cells 
Isolation and culture of alveolar epithelial cells were 
conducted according to the method previously described 
[17,18]. Male, pathogen-free, Sprague-Dawley rats (125- 
150 g) were anesthetized with pentobarbital sodium (150 
mg/kg body wt.) and the lungs were removed. They were 
perfused with 0.9% NaC1 to remove blood cells, and free 
alveolar macrophages were removed by tracheal avage 
with PBS. The lungs were then excised and filled with 
PBS containing elastase (40 U/ml,  type I, US Biochemi- 
cal) and DNase (0.006%, Sigma) and incubated at 37°C for 
20 min to free lung cells. After enzymatic digestion, the 
lungs were finely minced and the digestion was arrested by 
incubation for 5 rain in PBS containing 25% fetal bovine 
serum and 0.006% DNase. The crude extract was sequen- 
tially filtered through 160 and 45 /xm screens, centrifuged, 
and the resulting cell pellet was spun on a sterile Percoll 
density gradient. The second cell band from the surface 
was collected, washed twice, and resuspended in 1:1 F~2 
and Eagle's modified minimum essential medium plus 
10% fetal bovine serum, 100 U/ml  penicillin, 10 /zg/ml 
gentamicin, and 0.1 /zg/ml dexamethasone. Cell number 
and purity of cell preparations were determined using a 
Coulter model Z B electronic ell counter with a cell-sizing 
attachment (Coulter Instruments, Hialeah, FL). The aver- 
age values for these parameters were: yield = 15-20 × 10 6 
cells/rat; purity > 95%. Cell viability was measured via 
Trypan blue exclusion and was found to be greater than 
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95%. The suspended cells were plated onto 0.4-/xm pore, 
1.2-cm 2 tissue culture-treated Nuclepore filters (Transwell, 
Costar, Cambridge, MA) at 1.5 × 106 cells/cm 2 in 12-well 
plates. The cells on filters were maintained in a humidified 
5% CO 2 incubator at 37°C and the nutrient medium was 
changed every 48 h after plating. Cell confluence was 
monitored by electrical resistance measurements u ing the 
Millicell ERS testing device (Millipore, Bedford, MA). A 
typical peak resistance value of the resulting type I-like 
monolayers (normally obtained after 6 days) is--~ 1.5 
k,O.cm 2. Previous studies by Danto et al. [19] showed that 
the monolayers grown in culture under this condition 
exhibited a phenotypic haracteristic of type I epithelial 
cells. 
2.3. Permeability studies 
The monolayers on filters were incubated with Hepes- 
buffered medium (136 mM NaC1, 2.2 mM Na2HPO 4, 5.3 
mM KC1, 10 mM Hepes, 5.6 mM glucose, 1.0 mM CaC12, 
pH 7.4) at 37°C. After an equilibration period of 1 h, the 
apical medium was added with hydrogen peroxide (0.1-10 
mM) in the presence of the permeability marker ~4C 
mannitol (1 /xCi/ml). In some experiments in which the 
role of iron in oxidant-induced permeability change was to 
be evaluated, deferoxamine (1 mM) or FeSO 4 (1 raM) was 
also added to the apical medium. The appearance of the 
radioactivity in the basal medium was then monitored at 
various time intervals. Monolayer permeability was calcu- 
lated from the equation; Papp = J ss /Cd  = 
(dm/dt)( l /A.Cd), where Papp is the apparent permeabil- 
ity, Jss is the steady state flux, Cd is the apical radioactive 
concentration, m is the amount ransferred, and A is the 
exposed surface area. In experiments designed to assess 
the protective ffect of antioxidants, the monolayers were 
preexposed to catalase or transferrin-catalase conjugate 
(0.1-10 U/ml)  for 1 h at 37°C, after which they were 
washed with Hepes-buffered medium containing excess 
free transferrin (1 /zg/ml). Subsequently, they were treated 
with hydrogen peroxide as described above, All test agents 
were added to the apical surface of the monolayers. 
2.4. Determination of cellular damage 
The monolayers were incubated at 37°C in Hepes- 
buffered medium consisting 1 /xg/ml propidium iodide. 
After oxidant treatments, the monolayers were removed 
and their fluorescence intensity was measured using the 
Spex photon counter (SPEX-ARCM system, Spex Indus- 
tries, NJ) at the excitation and emission wavelengths of 
490 nm and 600 nm respectively. Cellular damage was 
calculated from nuclear fluorescence intensities according 
to the equation [31]; 
% Damaged Cells 
Measured signal - Minimum signal 
= × 100% 
Maximum signal - Minimum signal 
The maximum signal is the fluorescence signal obtained 
in the presence of Triton X-100 (0.1%) which was used to 
permeabilize the cells. The minimum signal is the back- 
ground autofluorescence signal. 
2.5. ESR measurements of  free radical formation 
ESR spectra were obtained at X-band (= 9.7 GHz) 
using a Bruker ER 200D ESR spectrometer. For the mea- 
surements of the g-values and hyperfine splittings, the 
magnetic field was calibrated with a self-tracking NMR 
gaussmeter (Bruker ER035M) and the microwave fre- 
quency was measured with a frequency counter (Hewlett- 
Packard 5340A). The microwave power and magnetic field 
modulation amplitude were adjusted to obtain optimal ESR 
signal resolution and intensity; typical spectrometer set- 
tings are given in the figure legend. 5,5-dimethyl-l-pyrro- 
line-N-oxide (DMPO, Aldrich) was used as a spin trap for 
the hydroxyl radical detection. All measurements were 
made at room temperature. 
2.6. Measurements of intracellular catalase actiL, iO, 
The monolayers were incubated for 1 h at 37°C in 
Hepes-buffered medium containing 2',7'-dichlorofluorescin 
diacetate (DCFHDA, 10 /zM) (Molecular Probes) in the 
presence of 1 U/ml catalase or catalase conjugate. The 
monolayers were washed and treated with 1 mM hydrogen 
peroxide for an additional 1 h as previously described. 
They were then washed and their fluorescence intensities 
were determined using the SPEX-ARCM system at the 
excitation and emission wavelengths of 490 nm and 530 
nm respectively. All test agents were added to the apical 
surface of the monolayers. DCFHDA was used in this 
study as an intracellular oxidative probe and as an indica- 
tor for antioxidant enzyme uptake. DCFHDA is a mem- 
brane perrneant molecule which can be hydrolyzed by 
non-specific esterases to yield 2',7'-dichlorofluorescin, a 
polar compound which is retained in intact cells. Upon 
oxidation by hydrogen peroxide, 2',7'-dichlorofluorescin is 
converted to the highly fluorescent 2',7'-dichlorofluo- 
rescein which can be monitored fluorometrically [20]. In 
the presence of enhanced concentration f catalase, hydro- 
gen peroxide is scavenged and less dichlorofluorescein 
fluorescent product is formed; therefore reduced cellular 
fluorescence indicates increased catalase uptake. 
3. Results 
3.1. Oxidant-induced permeabili~ alterations and cell in- 
jury 
Incubation of alveolar epithelial monolayers with hy- 
drogen peroxide (0.1-10 mM) caused a dose-dependent 
increase in alveolar permeability to mannitol (Papp) from 
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Fig. 1. Effects of hydrogen peroxide concentration on transepithelial 
permeability and cell damage in Flter-grown alveolar epithelial cell 
monolayers. Hydrogen peroxide ~,.1-10 raM) and [14C]mannitol (1 
/.~Ci/ml) was added concomitantly to the apical medium of the mi- 
croplate filters, and the monolayers were allowed to be incubated for 2 h 
at 37°C. The appearance of radioactivity in the basal medium was then 
determined and used to calculate the apparent permeability according to 
the equation described in Section 2. For cell damage studies, propidium 
iodide (1 ~g/ml) was used instead of [14C]mannitol, and nuclear fluores- 
cence was measured. Each column represents he mean of triplicate cell 
monolayers with a standard deviation which is indicated as a bar. 
* significant increase over control (P < 0.05). 
4.2 X 10 -7 to 12.8 X 10 -7 cm/s ,  as compared to 3.4 X 
10 -7 cm/s  for the untreated control (Fig. 1). Measure- 
ments of  nuclear propidium iodide f luorescence indicated a 
similar dose response for cellular damage; however,  this 
effect was not observed until the peroxide concentration 
was raised to 10 mM, i.e., 14% as compared to 4% for the 
control (Fig. 1). At a lower concentration (1 raM), hydro- 
gen peroxide induced a 91% increase in alveolar perme- 
ability but had no effect on cell damage, suggesting a 
greater susceptibil ity of the cell monolayers to permeabil -  
ity change than to damage. To find out whether these 
oxidative changes are mediated by cellular iron, experi- 
ments were repeated with the addition of the iron chelator 
deferoxamine (1 raM). In this case the measured Papp was 
3.9 x 10 -7 cm/s  and the cell damage was 5% (Fig. 2), 
thus suggesting the potential role of iron and possibly the 
formation of the highly reactive hydroxyl radicals via the 
iron-mediated Fenton reaction. Deferoxamine alone had no 
signif icant effects on the two membrane parameters (data 
not shown). Because of the potential involvement of hy- 
droxyl radicals in hydrogen peroxide- induced toxicity, ex- 
ogenously generated hydroxyl radical system was pro- 
duced (via the Fenton reaction, Fe2++ H202 ~ Fe3++ 
OH +.  OH)  and exposed to the monolayers, In this ex- 
periment a much greater increase in both the Papp (27.2 X 
10 -7 cm/s )  and cell damage (38%) was observed (Fig. 2). 
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Fig. 2. Effects of iron chelator and exogenous iron on hydrogen 
peroxide-induced permeability alterations and cell damage. Monolayers 
were exposed to [14C]mannitol (1 /zCi/ml) or propidium iodide (I 
/.~g/ml) for 2 h at 37°C in the absence (A) or presence of (B) 10 mM 
hydrogen peroxide, or (C) same as B + 1 mM deferoxamine, or(D) same 
as B + 1 mM FeSO 4. Each column represents he mean of triplicate cell 
monolayers with a standard deviation which is indicated as a bar. 
Significant increase over control A (P < 0.05). 
were treated with hydrogen peroxide in the presence of the 
spin trap DMPO,  a small but detectable ESR spectrum 
(g  -- 2.0059), consisting of  a 1:2:2:1 quartet pattern with a 
splitting of  14.9 G, which is characteristic of DMPO- -  OH 
adduct [21] was observed (Fig. 3A). In the presence of 
deferoxamine or in the absence of  cells, hydrogen peroxide 
J 
Magnetic Field 
lOG 
A 
B 
C 
D 
E 
3.2. E lectron spin resonance measurements  
To further conf irm that the hydroxyl radical was actu- 
ally formed under the test conditions, spin-trap ESR stud- 
ies were carried out. As shown in Fig. 3, when the cells 
Fig. 3. Electron spin resonance spectra observed after mixing 10 mM 
DMPO with 10 mM hydrogen peroxide in the presence of cell monolay- 
ers (A). (B) same as A but with 1 mM deferoxamine. (C) same as A but 
in the absence of cell monolayers. (D) same as A but with 1 mM FeSO 4. 
(E) same as A but with 30% ethanol. Modulation amplitude, 2G; scan 
time, 100 s; field, 3460+_75G. 
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produced undetectable ESR signals (Fig. 3B, 3C), thus 
confirming the formation of hydroxyl radicals in hydrogen 
peroxide-treated cells. When the cells were treated irectly 
with hydroxyl generating system (FeSO 4 + H202), the 
intensity of the DMPO- .  OH signal was greatly en- 
hanced (Fig. 3D). An addition of a secondary trap, ethanol, 
to this system caused a decrease in the intensity of the 
DMPO-, OH signal because thanol served as a scavenger 
for the hydroxyl radicals (Fig. 3E). The reaction of hy- 
droxyl radicals with ethanol results in the production of 
ethanolyl radicals which in turn react with DMPO to give 
the spin adduct DMPO-CHOHCH 3. The characteristic ESR 
signal of this DMPO-CHOHCH 3 adduct was observed, as 
indicated by arrows in Fig. 3E. These results indicate that 
hydroxyl radicals are indeed formed under the experimen- 
tal conditions. The observation of hydroxyl radical forma- 
tion in hydrogen peroxide-treated cells (even in the ab- 
sence of added iron) also suggests that hydrogen peroxide 
reacts with endogenous iron to form hydroxyl radicals. 
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Fig. 5. Inhibition of intracellular oxidation by catalase and transferrin- 
catalase conjugate. Monolayers were exposed to (A) buffer, (B) I U /ml  
catalase, or (C) I U /ml  catalase conjugate, at the apical surface in the 
presence of DCFHDA (10 p,M) for l h at 37°C. The monolayers were 
rinsed, treated with 1 mM hydrogen peroxide (1 h, 37°C) and their 
cellular fluorescence intensities were measured. (D) Indicates hydrogen 
peroxide-untreated control. Each column represents he mean of triplicate 
cell monolayers with a standard eviation which is indicated as a bar. 
* Significant increase over control A (P < 0.05). 
3.3. Preuention of oxidatice damage by catalase-transfer- 
rin cm~jugate 
To test whether native catalase can prevent alveolar 
damage and permeability alterations caused by hydrogen 
peroxide, the cell monolayers were treated with varying 
concentrations of catalase (0.1-10 U/ml), after which 
they were exposed to hydrogen peroxide (10 raM). At a 
catalase concentration of _<l U/ml, no protection was 
observed as indicated by the Papp and cell damage values 
of 12.0 × 10 -7 cm/s  and 15% (at 1 U/ml), compared with 
control values (non-enzyme-treated) of 12.8× l0 7 
cm/s and 17% respectively (Fig. 4). However, at the 
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Fig. 4. Dose effects of catalase and transferrin-catalase conjugate on 
hydrogen peroxide-induced permeability alterations and cell damage. 
Monolayers were preexposed to (A) buffer, (B) 0.1 U /ml  catalase, (C) 1 
U /ml  catalase, (D) 10 U /ml  catalase, (E) 0.1 U /ml  conjugate, (F) 1 
U /ml  conjugate, or (G) 10 U /ml  conjugate, at the apical surface for 1 h 
at 37°C. The monolayers were rinsed and treated with l0 mM hydrogen 
peroxide in the presence of [14C]mannitol (1 /zCi/ml) or propidium 
iodide (1 /~g/ml) according to the procedure described in Fig. 1. Each 
column represents he mean of triplicate cell monolayers with a standard 
deviation which is indicated as a bar. * significant increase over control 
A (P < 0.05). 
catalase concentration of l0 U/ml, both oxidant effects 
were partially blocked, i.e., Papp = 9.7 X 10 -7 cm/s  and 
cell damage = 11%. In contrast to native catalase, the 
transferrin-catalase conjugate was found to be more effec- 
tive at all three concentrations tested (Fig. 4). At 10 U/ml, 
the conjugate completely inhibited both oxidative effects 
(Papp = 3.6 × l0  -7  cm/ /s ,  cell damage = 4%). At lower 
concentrations, a 73% and 77% reduction in Papp and cell 
damage was observed at 1 U/ml, and 38% and 46% 
reduction at 0.1 U/ml. Because transferrin possesses an 
iron binding capability, we also tested whether the in- 
hibitory effects of the conjugate could be due to transfer- 
rin. Transferrin alone exhibited no protective ffect on 
oxidative damage or permeability alterations, and transfer- 
rin in combination with free catalase had comparable 
protective ffects as catalase alone (data not shown). 
3.4. Enzyme delicer3, cia tran~ferrin-catalase conjugate 
To verify that the enhanced protective ffect of transfer- 
rin-catalase conjugate was due to increased uptake of the 
enzyme conjugate, we analyzed intracellular catalase activ- 
ity following conjugate treatment. In these studies, cells 
were loaded with the intracellular oxidative probe dichlo- 
rofluorescin diacetate (10 p,M) and treated with catalase or 
catalase conjugate (1 U/ml). Subsequently, the cells were 
washed with buffer containing excess free transferrin (1 
p~g/ml) to remove non-internalized conjugate, exposed to 
hydrogen peroxide (1 raM), and their fluorescence intensi- 
ties were measured. As shown in Fig, 5, catalase-pretreated 
cells exhibited no significant enhancement i  catalase ac- 
tivity as indicated by the maintenance of the fluorescence 
signal that was generated by the oxidized probe, i.e., 
1.32 X 106 cps compared to 1.38 X 106 cps for hydrogen 
peroxide-treated control. In contrast, when the cells were 
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Fig. 6. Mechanism of enzyme uptake mediated by transferrin-catalase 
conjugate. Monolayers were preloaded with DCFHDA (10 /~M) in the 
absence (A) or presence of (B) 1 U/ml  transferrin-catalase, or (C) same 
as B+0.1 /zg/ml free transferrin, or (D) same as B+I  ~g/ml  free 
transferrin, or (E) same as B + 1 /~g/ml albumin, at the apical surface for 
1 h at 37°C. The monolayers were rinsed, treated with 1 mM hydrogen 
peroxide (1 h, 37°C) and their cellular fluorescence was determined. Each 
column represents he mean of triplicate cell monolayers with a standard 
deviation which is indicated as a bar. * Significant increase over control 
B (P < 0.05). 
treated with transferrin-catalase conjugate, a significant 
increase in intracellular catalase activity, which is indi- 
cated by a decrease in fluorescence signal (0.55 X l0 6 
cps), was observed. This fluorescence value was compara- 
ble to that of the hydrogen peroxide-untreated control 
(0.51 X 106 cps), suggesting that the normal oxidative 
state of the ceils is preserved when the cells were pre- 
treated with the conjugate and then exposed to hydrogen 
peroxide. 
3.5. Mechanism of enzyme uptake mediated by 
transferrin-catalase conjugate 
To further confirm that the enzyme conjugate was taken 
up endocytically via the transferrin receptor pathway, com- 
petitive inhibition studies for the receptor were conducted. 
The conjugate alone (1 U/ml  or = 0.01 /zg/ml) or in 
combination with excess transferrin (0.1-1 /zg/ml) was 
evaluated for their ability to inhibit intracellular dichlo- 
rofluorescein fluorescence in response to hydrogen perox- 
ide (Fig. 6). In this study, the conjugate alone inhibited 
intracellular oxidation much greater than did the conjugate 
in the presence of free transferrin. Increasing the amount 
of transferrin in the incubating medium lessened the in- 
hibitory effect of the conjugate, i.e., 60% and 22% reduc- 
tion in the presence of 0.1 and 1 p+g/ml transferrin 
respectively. Moreover, non-specific ompetition for the 
transferrin receptor by albumin (1 /zg/ml) was found to 
be ineffective in blocking such effect. Transferrin or albu- 
min alone had no significant effect on cellular fluorescence 
response, indicating that the inhibitory effect of the conju- 
gate requires the presence of catalase. To further demon- 
strate that the enhanced inhibitory effect of transferrin- 
catalase conjugate was not simply due to binding of the 
conjugate to the cell surface, experiments were repeated 
but at 4°C (the condition known to inhibit endocytic 
uptake but not binding). Under this condition, the conju- 
gate exhibited no improved antioxidant effect over the free 
catalase control. Thus, our results showed that the uptake 
of transferrin-catalase conjugate occurred via the transfer- 
rin receptor-mediated pathway and that the therapeutic 
effect of the conjugate requires functional domains capable 
of both oxidative inhibition and cell-surface receptor 
recognition. 
4. Discussion 
Excessive xposure to inhaled oxidants often results in 
pulmonary injury and inflammation. The pulmonary per- 
meability barrier, in particular, is highly susceptible to 
oxidant injury. Accumulating evidence suggests that reac- 
tive oxygen products formed at specific intracellular sites 
are likely to be the major cause of oxidative damage. 
However, the exact nature of these products in the alveolar 
epithelium has not been identified. Increased formation of 
hydrogen peroxide and superoxide radical can produce 
direct cellular damage. Although these oxygen products 
are not very reactive by themselves, they can interact in 
the presence of suitable transition metal catalysts to form 
the highly toxic hydroxyl radical and other oxygen-related 
products [22,23]. In addition, hydrogen peroxide can dif- 
fuse freely, as compared to oxygen radicals, through the 
epithelial cell membrane [24] and, therefore, radical gener- 
ation may have widespread consequences for the whole 
cell or tissue. 
Catalase has been suggested as a therapeutic means to 
treat pathological processes in which reactive oxygen 
metabolites are involved. Indeed, several attempts have 
been made to protect he cells from oxidative damage by 
catalase. However, its therapeutic application has been 
limited largely due to problems associated with its large 
molecular size and charge which prevents its intracellular 
uptake. In the present study, we demonstrated that, by 
conjugating the native enzyme catalase to the endocytic 
carrier transferrin, effective enzyme uptake can be 
achieved. This enhanced uptake was also found to corre- 
late well with the ability of the cells to protect against 
oxidative stress induced by hydrogen peroxide. 
Hydrogen peroxide can cause oxidative damage in a 
wide variety of cells and tissues. In alveolar epithelial 
cells, our results also indicate that hydrogen peroxide can 
induce permeability alterations even in the absence of cell 
damage (Fig. 1). This observation may have pathological 
significance since several previous tudies have shown that 
lethal exposure of animals to hyperoxia resulted in only 
minor or no destructive changes in type I alveolar epithe- 
lium [25-27]. The severity of the oxidant effects on epithe- 
lial permeability and injury appears to depend on the 
formation of hydroxyl radicals mediated by the Fenton 
iron catalyst. Thus, chelation of the cellular pool of iron by 
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deferoxamine l ssened the effects of hydrogen peroxide 
while the addition of ferrous ion to the incubating medium 
strengthened these effects (Fig. 2). Direct evidence for the 
formation of reactive hydroxyl radicals was demonstrated 
in our ESR studies (Fig. 3). In the absence of cells, 
hydrogen peroxide alone did not generate any significant 
radical signal, but in the presence of cells, a small but 
significant signal was detected, suggesting that endogenous 
iron may catalyze this reaction. Little is known about the 
nature of the intracellular iron pool, but accumulating 
evidence suggests that it consists of iron bound to the 
storage protein ferritin or to chelators of low molecular 
weight such as citrate, adenosine triphosphate, or adeno- 
sine diphosphate. All these forms of iron can stimulate 
radical reactions uch as the generation of hydroxyl radical 
from hydrogen peroxide [28]. In addition, hydrogen perox- 
ide may react with loosely bound transition metals on the 
epithelial cell surface [24] and directly damage the mem- 
branes. This result suggests that cellular toxicity of hydro- 
gen peroxide is at least in part due to hydroxyl radical 
generation. In other cell types such as hepatocytes, cardiac 
myocytes, and macrophages, tudies have shown that ox- 
idative injury caused by peroxides depends on the forma- 
tion of hydroxyl or alkoxyl radicals and that inhibition of 
this radical formation prevents the cells from oxidative 
injury [29-31]. 
Exposure of catalase to the cell monolayers had no or 
only partial protective ffects on oxidant injury and perme- 
ability alterations, depending on the dose (Fig. 4). Intracel- 
lular enzyme uptake studies indicated that catalase was 
minimally taken up by the cells under the test conditions 
(Fig. 5). Catalase is a negatively charged protein and 
therefore is repelled from the epithelial membrane surface 
[32]. Enhanced cellular association of the protein was 
observed when the enzyme is conjugated with transferrin, 
the molecule that binds and is internalized by the cells 
(Fig. 5). This enhanced uptake resulted in increased protec- 
tion of the cells from oxidative stress (Fig. 4). The protec- 
tive effects of transferrin-catalase conjugate were not due 
to the possible antioxidant action of transferrin since trans- 
ferrin alone did not prevent oxidative ffects. Transferrin is 
capable of binding iron; however, such binding did not 
result in enhanced protection or acceleration of oxidative 
injury [33,34]. Competition studies showed that transferrin 
promoted cellular uptake of the enzyme through transferrin 
receptor-mediated endocytosis pathway (Fig, 6). This ob- 
servation is consistent with previous findings which indi- 
cate specific binding and subsequent internalization of 
transferrin-enzyme conjugate via receptor-mediated endo- 
cytosis pathway [13,35]. The kinetics of uptake and recy- 
cling of this conjugate were also demonstrated to be 
similar to those of the native transferrin [35]. The highly 
efficient nature of the process as well as the conjugate's 
ability to withstand enzymatic degradation in endocytic 
vesicles [13] may explain the effectiveness of the conju- 
gate system in our study. 
The use of transferrin-catalase conjugate may poten- 
tially be useful in the treatment of those clinical disorders 
where oxidant oxicity is involved. However, in vivo stud- 
ies of this conjugate system remain to be established. The 
presence of a relatively high level of native transferrin in 
the pulmonary lining fluid [36] raises the question of 
possible competition for receptors and thus the therapeutic 
uptake of the transferrin conjugate. However, the natural 
presence of transferrin in the lung fluid also suggests the 
potential safety of this approach. 
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